Literature DB >> 7529771

Strategies for mapping and imitating viral B-cell epitopes.

J Cason1.   

Abstract

Identification of viral B-cell epitopes is of importance in the selection of peptides for inclusion into subunit vaccines, the development of virus-specific serological tests and understanding the interaction of antibodies with viruses at a molecular level. B-cell epitopes can often be determined unequivocally by X-ray analyses of antibody-antigen complexes. This technique is, however, time-consuming and alternative strategies have now been developed for identifying epitopes. This article provides an overview of approaches which are currently available for mapping and imitating B-cell epitopes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529771      PMCID: PMC7173103          DOI: 10.1016/0166-0934(94)90045-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  38 in total

1.  Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1.

Authors:  J P Langedijk; N K Back; P J Durda; J Goudsmit; R H Meloen
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

2.  Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.

Authors:  R H Meloen; W C Puyk; D J Meijer; H Lankhof; W P Posthumus; W M Schaaper
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

3.  A priori delineation of a peptide which mimics a discontinuous antigenic determinant.

Authors:  H M Geysen; S J Rodda; T J Mason
Journal:  Mol Immunol       Date:  1986-07       Impact factor: 4.407

4.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

5.  Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies.

Authors:  M Harper; F Lema; G Boulot; R J Poljak
Journal:  Mol Immunol       Date:  1987-02       Impact factor: 4.407

6.  Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.

Authors:  L D Papsidero; M Sheu; F W Ruscetti
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.

Authors:  J Cason; D Patel; J Naylor; D Lunney; P S Shepherd; J M Best; D J McCance
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

8.  Peptides on phage: a vast library of peptides for identifying ligands.

Authors:  S E Cwirla; E A Peters; R W Barrett; W J Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

10.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

Authors:  G P Smith
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

View more
  3 in total

Review 1.  Review on the identification and role of Toxoplasma gondii antigenic epitopes.

Authors:  Yanhua Wang; Guangxiang Wang; Jianping Cai; Hong Yin
Journal:  Parasitol Res       Date:  2015-11-19       Impact factor: 2.289

2.  Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients.

Authors:  H C Wu; Y L Huang; T T Chao; J T Jan; J L Huang; H Y Chiang; C C King; M F Shaio
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 3.  Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.

Authors:  Mar Forner; Rodrigo Cañas-Arranz; Sira Defaus; Patricia de León; Miguel Rodríguez-Pulido; Llilianne Ganges; Esther Blanco; Francisco Sobrino; David Andreu
Journal:  Vaccines (Basel)       Date:  2021-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.